These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28916119)

  • 21. Direct replacement of oral sodium benzoate with glycerol phenylbutyrate in children with urea cycle disorders.
    Yeo M; Rehsi P; Dorman M; Grunewald S; Baruteau J; Chakrapani A; Footitt E; Prunty H; McSweeney M
    JIMD Rep; 2022 Mar; 63(2):137-145. PubMed ID: 35281661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.
    De Las Heras J; Aldámiz-Echevarría L; Martínez-Chantar ML; Delgado TC
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):439-448. PubMed ID: 27860485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring the treatment of urea cycle disorders using phenylbutyrate metabolite analyses: Still many lessons to learn.
    Glinton KE; Minard CG; Liu N; Sun Q; Elsea SH; Burrage LC; Nagamani SCS
    Mol Genet Metab; 2023 Nov; 140(3):107699. PubMed ID: 37717413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary study of glyceryl phenylbutyrate therapy for Ornithine transcarbamylase deficiency and a literature review].
    Zhou D; Shang X; Qiao Y; Cheng Y; Yu Z; Huang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Sep; 40(9):1107-1112. PubMed ID: 37643956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare disease clinical research network's urea cycle consortium delivers a successful clinical trial to improve alternate pathway therapy.
    Mistry PK
    Hepatology; 2013 Jun; 57(6):2100-2. PubMed ID: 23080135
    [No Abstract]   [Full Text] [Related]  

  • 26. Glycerol phenylbutyrate for the chronic management of urea cycle disorders.
    Oishi K; Diaz GA
    Expert Rev Endocrinol Metab; 2014 Sep; 9(5):427-434. PubMed ID: 30736206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taste-masked formulation of sodium phenylbutyrate (ACER-001) for the treatment of urea cycle disorders.
    Cederbaum SD; Edwards J; Kellmeyer T; Peters Y; Steiner RD
    Mol Genet Metab; 2023 Apr; 138(4):107558. PubMed ID: 37004302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders.
    Burrage LC; Jain M; Gandolfo L; Lee BH; ; Nagamani SC
    Mol Genet Metab; 2014; 113(1-2):131-5. PubMed ID: 25042691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders.
    Posset R; Gropman AL; Nagamani SCS; Burrage LC; Bedoyan JK; Wong D; Berry GT; Baumgartner MR; Yudkoff M; Zielonka M; Hoffmann GF; Burgard P; Schulze A; McCandless SE; Garcia-Cazorla A; Seminara J; Garbade SF; Kölker S;
    Ann Neurol; 2019 Jul; 86(1):116-128. PubMed ID: 31018246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urea cycle disorder drug approved.
    Guha M
    Nat Biotechnol; 2013 Apr; 31(4):274. PubMed ID: 23563410
    [No Abstract]   [Full Text] [Related]  

  • 31. The burden of pharmacological treatment on health-related quality of life in people with a urea cycle disorder: a qualitative study.
    Yeowell G; Burns DS; Fatoye F
    J Patient Rep Outcomes; 2021 Oct; 5(1):110. PubMed ID: 34694515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between longitudinal changes in neuropsychological outcome and disease biomarkers in urea cycle disorders.
    Lichter-Konecki U; Sanz JH; ; McCarter R
    Pediatr Res; 2023 Dec; 94(6):2005-2015. PubMed ID: 37454183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder.
    Lee B; Diaz GA; Rhead W; Lichter-Konecki U; Feigenbaum A; Berry SA; Le Mons C; Bartley JA; Longo N; Nagamani SC; Berquist W; Gallagher R; Bartholomew D; Harding CO; Korson MS; McCandless SE; Smith W; Cederbaum S; Wong D; Merritt JL; Schulze A; Vockley J; Kronn D; Zori R; Summar M; Milikien DA; Marino M; Coakley DF; Mokhtarani M; ; Scharschmidt BF
    Genet Med; 2015 Jul; 17(7):561-8. PubMed ID: 25503497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycerol phenylbutyrate (Ravicti) for urea cycle disorders.
    Med Lett Drugs Ther; 2014 Aug; 56(1449):77-8. PubMed ID: 25118801
    [No Abstract]   [Full Text] [Related]  

  • 35. Unraveling the Link: Seizure Characteristics and Ammonia Levels in Urea Cycle Disorder During Hyperammonemic Crises.
    Chanvanichtrakool M; Schreiber JM; Chen WL; Barber J; Zhang A; Ah Mew N; Schulze A; Wilkening G; Nagamani SCS; Gropman A;
    Pediatr Neurol; 2024 Oct; 159():48-55. PubMed ID: 39121557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of urinary derivatives of Phenylbutyric and Benzoic acids by LC-MS/MS as treatment compliance biomarkers in Urea Cycle disorders.
    Andrade F; Vitoria I; Martín Hernández E; Pintos-Morell G; Correcher P; Puig-Piña R; Quijada-Fraile P; Peña-Quintana L; Marquez AM; Villate O; García Silva MT; de Las Heras J; Ceberio L; Rodrigues E; Almeida Campos T; Yahyaoui R; Blasco J; Vives-Piñera I; Gil D; Del Toro M; Ruiz-Pons M; Cañedo E; Barba Romero MA; García-Jiménez MC; Aldámiz-Echevarría L
    J Pharm Biomed Anal; 2019 Nov; 176():112798. PubMed ID: 31394303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients.
    Burlina AB; Ogier H; Korall H; Trefz FK
    Mol Genet Metab; 2001 Apr; 72(4):351-5. PubMed ID: 11286510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.
    Marini JC; Lanpher BC; Scaglia F; O'Brien WE; Sun Q; Garlick PJ; Jahoor F; Lee B
    Am J Clin Nutr; 2011 Jun; 93(6):1248-54. PubMed ID: 21490144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycerol Phenylbutyrate in Patients With Cirrhosis and Episodic Hepatic Encephalopathy: A Pilot Study of Safety and Effect on Venous Ammonia Concentration.
    Ghabril M; Zupanets IA; Vierling J; Mantry P; Rockey D; Wolf D; O'Shea R; Dickinson K; Gillaspy H; Norris C; Coakley DF; Mokhtarani M; Scharschmidt BF
    Clin Pharmacol Drug Dev; 2013 Jul; 2(3):278-84. PubMed ID: 27121790
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.